The role of apoptosis in the pathogenesis of the myelodysplastic syndromes

被引:39
作者
Parker, JE [1 ]
Mufti, GJ [1 ]
机构
[1] Guys Kings Thomas Sch Med, Dept Haematol Med, London SE5 8RX, England
关键词
apoptosis; MDS; AML; Fas; Bcl-2;
D O I
10.1007/BF02994003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The paradoxical occurrence of peripheral cytopenias despite a normo/hypercellular marrow in myelodysplastic syndromes (MDS) has been attributed to excessive intramedullary hematopoietic cell apoptosis. It has also been postulated that abrogation of programmed cell death (PCD) may underlie MDS transformation to acute myeloid leukemia (AML). Despite overwhelming evidence for a role of aberrant apoptosis in myelodysplasia, the molecular mechanisms responsible for such changes have not been elucidated. This paper summarizes current evidence implicating a role for altered PCD in MDS and outlines potential cellular mechanisms whereby hematopoietic progenitor cell apoptosis may be dysregulated. Int J Hematol. 2001:73:416-428. (C) 2001 The Japanese Society of Hematology.
引用
收藏
页码:416 / 428
页数:13
相关论文
共 153 条
[1]  
AguilarSantelises M, 1996, INT J CANCER, V69, P114, DOI 10.1002/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO
[2]  
2-3
[3]   Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro [J].
Aizawa, S ;
Nakano, M ;
Iwase, O ;
Yaguchi, M ;
Hiramoto, M ;
Hoshi, H ;
Nabeshima, R ;
Shima, D ;
Handa, H ;
Toyama, K .
LEUKEMIA RESEARCH, 1999, 23 (03) :239-246
[4]   Establishment of stromal cell line from an MDS RA patient which induced an apoptopic change in hematopoietic and leukemic cells in vitro [J].
Aizawa, S ;
Hiramoto, M ;
Hoshi, H ;
Toyama, K ;
Shima, D ;
Handa, H .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :148-155
[5]   Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes [J].
Ali, A ;
Mundle, SD ;
Ragasa, D ;
Reza, S ;
Shetty, V ;
Mativi, BY ;
Cartlidge, JD ;
Azharuddin, M ;
Qawi, H ;
Dar, S ;
Raza, A .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 1999, 8 (04) :343-356
[6]  
ANZAI N, 1994, LEUKEMIA, V8, P446
[7]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[8]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[9]   Autonomous proliferation and bcl-2 expression involving haematopoietic cells in patients with myelodysplastic syndrome [J].
Bincoletto, C ;
Saad, STO ;
da Silva, ES ;
Queiroz, MLS .
BRITISH JOURNAL OF CANCER, 1998, 78 (05) :621-624
[10]  
Binder C, 1999, ANTICANCER RES, V19, P1715